CCT Inhibitors

Santa Cruz Biotechnology now offers a broad range of CCT Inhibitors for use in various applications. CCT inhibitors target the chaperonin-containing TCP-1 (CCT) complex, also known as the TRiC complex, which is a group of molecular chaperones essential for the correct folding of many cytosolic proteins, including actin and tubulin. These chaperones are critical in maintaining cellular protein homeostasis by assisting in the proper folding and assembly of newly synthesized polypeptides and by preventing the aggregation of misfolded proteins. CCT is particularly important in the folding of proteins involved in cell cycle regulation and cytoskeletal dynamics, making it a key player in processes such as cell division and intracellular transport. Inhibitors of CCT are valuable tools for researchers aiming to study the detailed mechanisms of protein folding and to understand the role of CCT in various cellular pathways. These inhibitors are often used in studies investigating the impact of impaired protein folding on cell function and the potential consequences of CCT dysfunction in diseases characterized by protein misfolding, such as neurodegenerative disorders and cancer. By selectively inhibiting CCT activity, researchers can dissect the specific roles of this chaperonin complex in maintaining cellular homeostasis and explore its potential as a target for intervention in diseases caused by protein misfolding. View detailed information on our available CCT Inhibitors by clicking on the product name.